Humana Inc. vs Johnson & Johnson
HUM vs JNJ — side-by-side comparison from reported financials. HUM leads 4, JNJ leads 6 of 10 comparable metrics.
Humana Inc.
HUM · Healthcare
$438.49+13.27%Mixed
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | HUM | JNJ |
|---|---|---|
| Price | $438.49 | $261.79 |
| Market cap | $52.6B | $631B |
| Revenue (TTM) | $146B | $97.9B |
| Revenue growth | +11.8% | +5.6% |
| Net margin | 0.9% | 21.5% |
| Free cash flow | $1.95B | $22.2B |
| Net cash (debt) | $7.53B | ($27.8B) |
| 1-year price return | +50.9% | +37.0% |
| P/E | 40.5 | 29.9 |
| P/E vs own history (cheap-side %) | 0% | 16% |
| Dividend yield | 0.83% | 2.00% |
| Return on equity | 7% | 26% |
| Altman Z-score | 2.34 | — |
| CV checks passed | 10 of 11 | 10 of 11 |
| Employees | 67,060 | 140,800 |
Full résumé-style profiles: HUM CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.